The largest database of trusted experimental protocols

Laser Surgery

Laser surgery, also known as laser-assisted surgery, is a minimally invasive medical procedure that uses highly focused laser light to precisely cut, vaporize, or ablate tissue.
This technique has revolutionized many fields of medicine, including ophthalmology, dermatology, and oncology, by offering improved precision, reduced recovery time, and enhanced patient outcomes.
Laser surgery can be used to treat a variety of conditions, such as refractive errors, skin lesions, and cancerous tumors.
The use of lasers allows for more accuarate and reproducible procedures, enhancing the safety and effectiveness of these interventions.
Researchers continue to explore new applications and advancements in laser surgery, driven by the pursuit of improved patient care and outcomes.

Most cited protocols related to «Laser Surgery»

All control subjects were at least 60 years of age and matched according to age, gender, and ethnicity to the enrolled index cases. Controls were chosen to be five years older than their corresponding case to minimize the enrollment of controls who might later develop FECD and confound analysis. To qualify, each control subject was required to be grade 0 on the FECD grading scale, have no family history of a possibly inherited corneal disorder (e.g., FECD, keratoconus, stromal dystrophy), exhibit refractive astigmatism of less than 3.50D and have normal corneas with no abnormalities upon slit lamp examination other than the following noted exceptions: 1) peripheral degenerative changes related to age, including arcus senilis and limbal-girdle of Vogt, 2) corneal scar from infection or penetrating trauma, 3) pterygium or pterygium surgery, 4) inactive superficial vascularization of the epithelium and/or subepithelial layer, 5) previous glaucoma, or retina-vitreous surgery in one eye where the other eye had not had surgery and the endothelium was normal, 6) previous intraocular laser surgery. Bilateral pseudophakes who received an FECD grade of 0 and were FECD negative preoperatively also qualified. The limbal/peripheral corneal incisions related to cataract surgery were judged unlikely to affect the central cornea and, thus, the ability to assess the FECD phenotype. Subjects were excluded from participation as controls if they displayed any signs of corneal dystrophy or degeneration, had previous/active interstitial keratitis or anterior uveitis, or active/previous infectious keratitis or vascularization of the epithelium and/or stroma. Subjects were also excluded if they had previously undergone bilateral corneal surgery or had experienced perforating corneal trauma resulting in scarring.
Publication 2012
Arcus Senilis Astigmatism Cataract Extraction Congenital Abnormality Cornea Cornea Injuries Corneal Diseases Endothelium Epithelium Ethnicity Gender Glaucoma Hereditary Corneal Dystrophy Infection Keratitis Keratoconus Laser Surgery Limbus Corneae Ocular Refraction Operative Surgical Procedures Ophthalmologic Surgical Procedures Pathologic Neovascularization Phenotype Pterygium Of Conjunctiva And Cornea Retina Slit Lamp Examination Uveitis, Anterior Wounds, Penetrating
Findings from the CRYO-ROP trial10 (link) and ETROP trial12 (link) suggested that the recurrence rates with conventional laser therapy would be up to 50% for zone I disease and up to 20% for zone II posterior disease. The clinical data available at the time that we designed our study suggested that the recurrence rates after intravitreal bevacizumab monotherapy would be 10% for zone I disease and 1% for zone II posterior disease. Assuming a rate of death or loss to follow-up of 10%, we calculated that a sample of 24 participants per treatment group for zone I disease and 50 participants per treatment group for zone II posterior disease would be required to detect a significant difference in the rate of the primary outcome between the two treatment groups. Thus, to draw an overall conclusion regarding the efficacy of intravitreal bevacizumab in both zones, the study was designed to enroll a total of 150 infants, at least 50 of them with zone I retinopathy of prematurity.
Descriptive statistics from a two-sample t-test or Fisher’s exact test were used to evaluate whether the group of infants assigned to intravitreal bevacizumab and the group assigned to conventional laser therapy were similar before treatment with respect to demographic and clinical characteristics, including risk factors for retinopathy of prematurity. The primary ocular outcome, recurrence of retinopathy of prematurity, is a variable with three possible values: 0 for recurrence in neither eye, 1 for recurrence in one eye, and 2 for recurrence in both eyes. This outcome was evaluated by means of an ordered logistic-regression model. The primary analysis was an intention-to-treat analysis of all infants who were randomly assigned to a treatment group. Infants who died or were lost to follow-up were considered to have missing data in the primary analysis. We also carried out a post hoc sensitivity analysis in which deaths were considered to be recurrences. SAS for Windows software, version 9.1 (SAS Institute), was used to perform all statistical analyses. A P value of less than 0.05 was considered to indicate statistical significance.
Publication 2011
Bevacizumab Eye Hypersensitivity Infant Laser Surgery Recurrence Retinopathy of Prematurity Vision

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2012
Animals Axon Caenorhabditis elegans Cells Helminths Laser Surgery Medical Devices Microchip Analytical Devices

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Cells Chameleons Epistropheus Eye Immersion Laser Surgery Lens, Crystalline Light Microscopy Movement Nerve Tissue Ovarian Failure, Premature Sound Waves Transducers Ultrasonics

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Adult Animals Axon Dendrites Larva Laser Surgery

Most recents protocols related to «Laser Surgery»

The campaign was performed at the top of the Säntis mountain (2,502 m altitude) in north-eastern Switzerland, on the summit of which stands a 124-m-tall telecommunication tower. A general view of the experimental set-up is presented in Extended Data Fig. 1. The laser system was located in the radome building, sheltered in an air-tight, air-conditioned and thermally isolated tent. After exiting the tent, the laser output was directed downwards by a conduit through the radome wall to the terrace, where a 4′ folding mirror directed the beam into a beam-expanding sending telescope featuring a 7.14 magnification ratio. The entire laser path toward the telescope—presented in Extended Data Fig. 1a—was protected by an isolated aluminium housing to prevent any beam leakage and to reduce the perturbation from the environment.
The telescope was composed of an additional folding mirror, a secondary 100 mm spherical mirror and a 430-mm diameter off-axis aspheric (elliptic) primary mirror29 (link). The beam output, which had a diameter of 250 mm, was sent toward the tower tip with a vertical angle of 7°. Translation stages on the secondary mirror allowed us to focus the beam near the tower tip in order to set the onset of the filamentation process in the desired area in which upward lightning is initiated. The focal length of the telescope was set to 150 m to produce a dense filamentation area of 30–50 m above the tower tip.
Note that during the entire laser operation time, the airspace was closed by the air-traffic authority. Furthermore, air traffic was monitored by an automatic dependent surveillance–broadcast transceiver automatically switching off the laser in case of aircraft incursion into the temporary closed airspace zone.
Full text: Click here
Publication 2023
Aluminum Epistropheus Laser Surgery Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Telescopes
This was a single-surgeon, retrospective study of patients undergoing femtosecond laser-assisted cataract surgery with arcuate incisions for the reduction of astigmatism. Arcuate incision anatomy was calculated using the LaserArcs online nomogram. The primary endpoint of this study was the percent reduction in absolute magnitude of astigmatism in the subject population based upon the absolute difference of postoperative manifest refraction. Postoperative manifest cylinder was the exploratory endpoint.
All patients had undergone a preoperative manifest refraction, and keratometry was determined using an IOLmaster V (Carl Zeiss Meditec, Oberkochen, Germany) with software version 5.2.1 to 5.4 or a LenStar LS900 (Haag-Streit, Bern, Switzerland) version 4.2.1 to 4.4.0, which are comparable instruments for the purposes of corneal power measurement.12 (link) Posterior corneal astigmatism and central topography were both included in these calculations. Biometry data was manually uploaded to the online LaserArcs software for calculation, and a graphical printout (Figure 1) was generated for use in surgery.

The LaserArcs software graphical output. Reprinted with permission from LaserArcs.

All arcuate incisions were made to an 8.0 mm diameter at a depth 80% of the corneal thickness as measured by the OCT corneal depth measurement of the LenSx (Alcon, Ft Worth) femtosecond laser. Laser arcuate incisions were not further manipulated or opened by the surgeon. The femtosecond laser was also used to create an anterior capsulotomy of 5.5 mm and for lens fragmentation. No other incisions were made with the femtosecond laser. No toric lens implants were used in study eyes, and an attempt was made to include about 30% of patients receiving multifocal implants with preoperative cylinder less than 0.7 D, so the study could evaluate the common scenario of correcting astigmatism with a multifocal implant where a sufficiently low toric power is not available. All postoperative refraction data was collected one month after surgery.
A sample size estimation was performed using results from an independent data set of 400 eyes and determined that 50 unilateral eyes would provide >90% statistical power to demonstrate a clinically meaningful percent reduction of astigmatism with a target reduction of 60%. All enrolled subjects were required to be 22 years of age or older and had cataracts but otherwise healthy eyes, not exhibiting any significant ocular morbidity that would be expected to influence outcome measures. All patients had preoperative keratometric astigmatism greater than 0.25 D and were implanted with a non-toric IOL, and all patients’ laser astigmatic keratotomy was planned using the LaserArcs nomogram. Patients with visually significant co-morbidities that could affect their visual outcome after surgery, like corneal, retinal, or optic nerve disease, were excluded, and all patients had a preoperative corneal topography screening for ectasia, higher-order aberrations, or other abnormalities and would be excluded from treatment if significant corneal pathology were identified. Patients with surgical complications either during or after surgery (capsule tears, iris trauma, decentered IOL, cystoid macular edema, etc.) that would, in the judgment of the investigator, influence the outcome measures of the study, and patients with previous refractive surgery prior to cataract surgery were also excluded.
Prior to collection of retrospective data, this study was registered on ClinicalTrials.gov as NCT 05278442. It was also approved by WCG IRB (Puyallup, Washington) as protocol 20220599 and adhered to both the Declaration of Helsinki and good clinical practices as defined by the U.S. Food and Drug Administration. A waiver of written informed consent was provided by the IRB. Reasonable requests for de-identified patient data relating to the study findings will be available through the corresponding author for 5 years following the publication date.
Publication 2023
Astigmatism Capsule Cataract Cataract Extraction Congenital Abnormality Cornea Corneal Astigmatism Corneal Topography Eye Hepatitis A Antigens Iris Laser Surgery Lens, Crystalline Lens Implantation, Intraocular Macular Edema, Cystoid Neural-Optical Lesion Ocular Refraction Operative Surgical Procedures Pathological Dilatation Patients Retina Surgeons Surgeries, Refractive Tears Vision Wounds and Injuries
This was an observational cross-sectional study. A total of 100 healthy volunteers were enrolled from the Physical Examination Center of Guangdong Provincial People’s Hospital who underwent physical examinations from January 2020 to June 2020. Participants were between the age of 18 to 52 years (M = 34.43, SD = 8.75) and the diopter range of −8.94D to +1.63D (M = 2.91, SD = 2.42); 47 were males (47%) and 53 were females (53%). Grouped by age and diopter (Table 1). The daily time spent in near work was ranging from 2 h to more than 12 h (M = 7.65, SD = 3.11).
The inclusion criteria for participants were as followed: (1) Age range of 18–55 years, with good comprehension and communication skills; (2) Best corrected visual acuity 20/20 or above; (3) Normal eye movement.
The exclusion criteria for participants were as followed: (1) With a history of organic ocular disease or ocular surgery (except excimer laser surgery); (2) Dominant strabismus and other eye position errors detected by the 33 cm Hirschberg test and alternate cover test; (3) Those who were unable to complete the study or were required to withdraw due to any discomfort during the study.
Full text: Click here
Publication 2023
Eye Movements Females Healthy Volunteers Lasers, Excimer Laser Surgery Males Operative Surgical Procedures Physical Examination Strabismus Vision Visual Acuity
This nonrandomized prospective case series included patients scheduled for FLACS (FLACS group) or conventional cataract surgery (CCS group) in Vithas Eurocanarias Instituto Oftalmológico, Las Palmas de Gran Canaria, Spain. Written informed consent was obtained from each subject after receiving a full explanation of the procedure and the nature of the study. The study was approved by the local ethics committee and was performed in compliance with the tenets of the Declaration of Helsinki.
Inclusion criteria for both groups were age over 45 years old, cortical nuclear sclerotic grade II-III cataracts according to the Lens Opacities Classification System (LOCS) III classification, and axial length between 21.0 and 25.5 millimetres (mm). Exclusion criteria were previous ocular surgery, history of any systemic or ocular diseases (e.g., glaucoma, ocular hypertension, age related macular degeneration), any condition that could alter OCT results (e.g., peripapillary atrophy, difficulties in fixation, corneal opacities), low quality OCT images (image quality under 15), spherical equivalent refraction over 3 diopters, and intraoperative or postoperative complications. After a detailed explanation of both techniques, patients chose which surgical option they preferred; those who decided to have cataract surgery with femtosecond laser assistance comprised the FLACS group and the rest comprised the CCS group.
Full text: Click here
Publication 2023
Age-Related Macular Degeneration Atrophy Cataract Cataract Extraction Cortex, Cerebral Eye Glaucoma Granisetron Laser Surgery Ocular Hypertension Ocular Refraction Operative Surgical Procedures Patients Postoperative Complications Regional Ethics Committees Sclerosis
From our institutional database of patients diagnosed with laryngeal cancer between January 1980 and December 2021, we retrospectively extracted patients who experienced a locoregional recurrence after initial treatment for early glottic cancer, collecting their clinical and pathological information, such as age at first diagnosis, sex, smoking and alcohol abuse status, initial TNM stage at diagnosis, type of initial treatment (e.g., radiotherapy, transoral laser surgery, partial or total laryngectomy), disease-free interval, follow-up period, and cause of death. For each recurrence, we retrieved the rTNM, CLRSS, and CLRSS-2 stages, the chosen salvage treatment, distant metastases, and disease-free interval.
We included patients with an initial early glottic cancer (T1-T2 patients according to the 8th edition of the American Joint Committee on Cancer (AJCC), without lymph node involvement) [15 ] who had experienced recurrent disease after a disease-free interval of at least 3 months, and with a histological diagnosis of squamous-cell carcinoma. We excluded non-squamous-cell histology, patients who underwent a palliative treatment without curative intent, and patients with incomplete data.
The follow-up protocol, both for primary tumors and recurrences, was conducted by the medical staff (seniors and residents in otolaryngology) of our department, and it usually consisted of direct/indirect laryngoscopy every 4–8 weeks for the first 2 years, every 3 months for the 3rd year, every 6 months during the 4th and 5th years, and then once a year.
Full text: Click here
Publication 2023
Abuse, Alcohol Cancer of Tongue Diagnosis Joints Laryngeal Cancer Laryngectomy Laryngoscopy Laser Surgery Malignant Neoplasms Medical Staff N-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide Neoplasm Metastasis Neoplasms Nodes, Lymph Palliative Care Patients Radiotherapy Recurrence Salvage Therapy Squamous Cell Carcinoma Squamous Epithelial Cells

Top products related to «Laser Surgery»

Sourced in United States, Switzerland
The Centurion Vision System is a specialized ophthalmic surgical device designed for cataract surgery. It provides precise control and customization of various surgical parameters to assist ophthalmologists during the procedure.
Sourced in Germany
The Victus is a versatile lab equipment product from Bausch & Lomb. It is designed to perform a range of functions in a laboratory setting. The core function of the Victus is to provide reliable and efficient processing of various samples and materials.
Sourced in United States
The LenSx is a precision laser system designed for ophthalmic surgical procedures. It features advanced laser technology to assist with various steps of cataract surgery.
Sourced in Switzerland
The Centurion Vision is a surgical console that provides a comprehensive platform for cataract and refractive surgeries. It features advanced technology to support various ophthalmic procedures.
Sourced in United States
The LenSx platform is a laser-based system designed for ophthalmic surgical procedures. It is used to perform precise corneal and lens incisions during cataract and refractive surgery.
Sourced in United States
Protein Pilot v.3.0 is a software application developed by AB Sciex. The software's core function is to facilitate the analysis and identification of proteins from mass spectrometry data.
Sourced in United States
The VLS 4.60 is a versatile lab equipment designed for various scientific applications. It features a compact and durable construction, providing a stable platform for precise measurements and experiments. The device's core function is to perform accurate measurements and data collection, supporting a range of laboratory activities.
Sourced in United States, United Kingdom, Germany, Japan, Italy
LabVIEW is a graphical programming environment developed by National Instruments for creating and deploying measurement and control systems. Its core function is to provide users with a visual interface for designing, simulating, and executing programs.
Sourced in United States, Japan, United Kingdom, Belgium, Austria, Australia, Spain
SPSS is a comprehensive statistical software package that enables data analysis, data management, and data visualization. It provides a wide range of statistical techniques, including descriptive statistics, bivariate analysis, predictive analytics, and advanced modeling. SPSS is designed to help users efficiently manage and analyze large datasets, making it a valuable tool for researchers, statisticians, and data analysts.
Sourced in France
The VITRA 532 nm Photocoagulator is a medical device used in ophthalmology. It emits a laser beam with a wavelength of 532 nanometers (nm) to coagulate targeted areas of the eye. The device is designed for precision and controlled application of laser energy.

More about "Laser Surgery"